Giraffe Bio is a developer of biomolecular technology to improve efficiency and sustainability in critical mineral extraction. The
Giraffe Bio has raised $32K in total funding. The most recent round was Grant. The last funding was announced in February 2025.
Giraffe Bio's investors include SOSV, SOSV SF & NY (Fka IndieBio), Start-Up Chile, AIR Capital.
Giraffe Bio is headquartered in Buenos Aires, Argentina.
Giraffe Bio is a developer of biomolecular technology to improve efficiency and sustainability in critical mineral extraction. The
Giraffe Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Giraffe Bio — Funding & Investors." VCBacked, February 19, 2025, https://www.vcbacked.co/company/giraffe-bio. Accessed August 15, 2026.
VCBacked. (2025). Giraffe Bio — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/giraffe-bio
{{cite web |title=Giraffe Bio — Funding & Investors |url=https://www.vcbacked.co/company/giraffe-bio |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated